Key Takeaways
- Sector: Healthcare Healthtech & Medtech, Technology Software & Gaming.
- Geography: United States.
Analysis
Rivalry Capital has unveiled its launch as a next-generation private equity house dedicated to healthcare transformation. The firm blends applied mathematics and artificial intelligence with hands-on operating discipline and deep clinical expertise to identify and accelerate growth in the sector.
Jim Chandler CFA, Matt Young MBA, Robert Moghim MD, and Kian Modanlou MD, who bring a system-based, disciplined approach to value creation. Their framework combines quantitative rigor with practical industry insight to target companies that can redefine care delivery and outcomes at scale.
In a market characterized by fragmentation and rising cost pressures, the partners argue that the next five years will redefine how care is organized and paid for. Rivalry Capital emphasizes transparency, efficiency, and clinical relevance as core pillars of its strategy, aiming to partner with management teams delivering measurable improvements across the care ecosystem.
With a track record of $450 million in cumulative exits across their careers, the partners aim to translate that experience into accelerated growth for portfolio companies. This background provides a credible platform for integrating advanced analytics with clinical operations to drive faster, more durable value creation.
Rivalry Capital intends to back emerging and lower-middle-market healthcare and technology companies, leveraging data-driven insights to optimize product-market fit, reimbursement pathways, and patient outcomes. The firm’s thesis centers on using AI-enabled models to unlock performance improvements that traditional capital approaches may overlook.
Industry observers note that healthcare AI and digital health are expanding rapidly as providers and payers demand more efficient, transparent processes. Rivalry Capital’s formation aligns with this trend, positioning the firm to support growth-stage contenders that integrate technology, clinical expertise, and operating leverage to deliver scalable transformations.